SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-055978
Filing Date
2021-11-02
Accepted
2021-11-02 08:30:29
Documents
14
Period of Report
2021-10-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea149725-8k_180life.htm   iXBRL 8-K 38887
2 EMPLOYMENT AGREEMENT ea149725ex10-1_180life.htm EX-10.1 54115
  Complete submission text file 0001213900-21-055978.txt   331895

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE atnf-20211029.xsd EX-101.SCH 3790
4 XBRL DEFINITION FILE atnf-20211029_def.xml EX-101.DEF 26659
5 XBRL LABEL FILE atnf-20211029_lab.xml EX-101.LAB 36697
6 XBRL PRESENTATION FILE atnf-20211029_pre.xml EX-101.PRE 25277
7 EXTRACTED XBRL INSTANCE DOCUMENT ea149725-8k_180life_htm.xml XML 5567
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 211369385
SIC: 2834 Pharmaceutical Preparations